-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Brief introduction
Reye syndrome is an acute mitochondrial injury manifested by acute encephalopathy, selective liver impairment, and infiltration of visceral fat, with clinical changes such as encephalopathy and biochemical changes as liver disease
Diagnostic criteria
Children under 18 years of age, present
(1) Acute non-inflammatory encephalopathy (no increase in the number of cerebrospinal fluid cells);
(2) Characteristic liver disease pathology or serum aminotransferase or blood ammonia increase of more than 3 times the normal limit value;
(3) Exclude other diseases
pathogen
Reye syndrome is a mitochondrial disease whose cause is thought to be related
Imaging diagnostics
CT The density of white matter around the ventricles of the brain is significantly reduced, and the ventricles are compressed
It may also present with diffuse cortical and white matter changes, and in the acute phase manifest as a high cortical layered T2WI signal, which can be strengthened; Diffuse layered hypersignal in chronic phase T1WI; At the same time, white matter changes and brain atrophy